Ann: Cynata announces CEO succession and Board changes, page-32

Bioscience managers have taken two baths on cap raisings now in just cynata alone.

Doesn't reflect particularly well on their stock selection or commercialisation skills.

Where is Fujifilms change of substantial holding notice btw? Either they bought or they fell below the 5%.

They should have reported by now if they are below the 5% no? Wouldn't that be bad news that would be better put behind shareholders 'going forward' (hate that expression - going forward) but if there is to be a reboot, a fresh start better to get all the crap out of the way?

Does ASIC give a fig about this stuff? Or is it just another thing they don't much worry about?

Bioscicenc Managers can probably get their money back at something under 50 cents - so maybe that is where the takeover offers would be pitched if any.

I don't think Fujifilm need to do much except wait but their shareholding should be reported in my opinion as they do hold part of CYPs core patent - the hemangioblast patent - they get the bits related to derivation of cells other than MSCs from iPSCs and they (Fujifilm) would be a cheap opportunistic takeover candidate potentially.

I think Fujifilm should have reported the change in shareholding on that basis.